Acquired Loss of Function of CYP2C19 in Cancer Patients: Studies to Determine the Prevalence and the Possible Molecular Mechanisms of This Genotype- Phenotype Discordance
0 sources
Acquired Loss of Function of CYP2C19 in Cancer Patients: Studies to Determine the Prevalence and the Possible Molecular Mechanisms of This Genotype- Phenotype Discordance
Summary
Acquired Loss of Function of CYP2C19 in Cancer Patients: Studies to Determine the Prevalence and the Possible Molecular Mechanisms of This Genotype- Phenotype Discordance is a doctoral thesis[1].
Key Facts
- Acquired Loss of Function of CYP2C19 in Cancer Patients: Studies to Determine the Prevalence and the Possible Molecular Mechanisms of This Genotype- Phenotype Discordance authored Studies to Determine the Prevalence and the Possible Molecular Mechanisms of This Genotype- Phenotype Discordance — author (P50): Kathryn Elisa Burns[2].
- Acquired Loss of Function of CYP2C19 in Cancer Patients: Studies to Determine the Prevalence and the Possible Molecular Mechanisms of This Genotype- Phenotype Discordance's instance of is recorded as Studies to Determine the Prevalence and the Possible Molecular Mechanisms of This Genotype- Phenotype Discordance — instance of (P31): doctoral thesis[3].
- Acquired Loss of Function of CYP2C19 in Cancer Patients: Studies to Determine the Prevalence and the Possible Molecular Mechanisms of This Genotype- Phenotype Discordance's publisher is recorded as Studies to Determine the Prevalence and the Possible Molecular Mechanisms of This Genotype- Phenotype Discordance — publisher (P123): ResearchSpace@Auckland[4].
- Acquired Loss of Function of CYP2C19 in Cancer Patients: Studies to Determine the Prevalence and the Possible Molecular Mechanisms of This Genotype- Phenotype Discordance's copyright license is recorded as Studies to Determine the Prevalence and the Possible Molecular Mechanisms of This Genotype- Phenotype Discordance — copyright license (P275): Creative Commons Attribution-NonCommercial-ShareAlike 3.0 New Zealand[5].
- Acquired Loss of Function of CYP2C19 in Cancer Patients: Studies to Determine the Prevalence and the Possible Molecular Mechanisms of This Genotype- Phenotype Discordance's country of origin is recorded as Studies to Determine the Prevalence and the Possible Molecular Mechanisms of This Genotype- Phenotype Discordance — country of origin (P495): New Zealand[6].
- Acquired Loss of Function of CYP2C19 in Cancer Patients: Studies to Determine the Prevalence and the Possible Molecular Mechanisms of This Genotype- Phenotype Discordance's publication date is recorded as +2014-00-00T00:00:00Z[7].
- Acquired Loss of Function of CYP2C19 in Cancer Patients: Studies to Determine the Prevalence and the Possible Molecular Mechanisms of This Genotype- Phenotype Discordance's work available at URL is recorded as https://researchspace.auckland.ac.nz/handle/2292/23961[8].
- Acquired Loss of Function of CYP2C19 in Cancer Patients: Studies to Determine the Prevalence and the Possible Molecular Mechanisms of This Genotype- Phenotype Discordance's Handle ID is recorded as 2292/23961[9].
- Acquired Loss of Function of CYP2C19 in Cancer Patients: Studies to Determine the Prevalence and the Possible Molecular Mechanisms of This Genotype- Phenotype Discordance's title is recorded as Acquired Loss of Function of CYP2C19 in Cancer Patients: Studies to Determine the Prevalence and the Possible Molecular Mechanisms of This Genotype- Phenotype Discordance[10].
- Acquired Loss of Function of CYP2C19 in Cancer Patients: Studies to Determine the Prevalence and the Possible Molecular Mechanisms of This Genotype- Phenotype Discordance's copyright holder is recorded as Studies to Determine the Prevalence and the Possible Molecular Mechanisms of This Genotype- Phenotype Discordance — copyright holder (P3931): Kathryn Elisa Burns[11].
- Acquired Loss of Function of CYP2C19 in Cancer Patients: Studies to Determine the Prevalence and the Possible Molecular Mechanisms of This Genotype- Phenotype Discordance's thesis submitted to is recorded as Studies to Determine the Prevalence and the Possible Molecular Mechanisms of This Genotype- Phenotype Discordance — thesis submitted to (P4101): University of Auckland[12].
- Acquired Loss of Function of CYP2C19 in Cancer Patients: Studies to Determine the Prevalence and the Possible Molecular Mechanisms of This Genotype- Phenotype Discordance's on focus list of Wikimedia project is recorded as Studies to Determine the Prevalence and the Possible Molecular Mechanisms of This Genotype- Phenotype Discordance — on focus list of Wikimedia project (P5008): NZThesisProject[13].
- Acquired Loss of Function of CYP2C19 in Cancer Patients: Studies to Determine the Prevalence and the Possible Molecular Mechanisms of This Genotype- Phenotype Discordance's copyright status is recorded as Studies to Determine the Prevalence and the Possible Molecular Mechanisms of This Genotype- Phenotype Discordance — copyright status (P6216): copyrighted[14].
- Acquired Loss of Function of CYP2C19 in Cancer Patients: Studies to Determine the Prevalence and the Possible Molecular Mechanisms of This Genotype- Phenotype Discordance's online access status is recorded as Studies to Determine the Prevalence and the Possible Molecular Mechanisms of This Genotype- Phenotype Discordance — online access status (P6954): open access[15].
- Acquired Loss of Function of CYP2C19 in Cancer Patients: Studies to Determine the Prevalence and the Possible Molecular Mechanisms of This Genotype- Phenotype Discordance's thesis committee member is recorded as Studies to Determine the Prevalence and the Possible Molecular Mechanisms of This Genotype- Phenotype Discordance — thesis committee member (P9161): Nuala Helsby[16].
- Acquired Loss of Function of CYP2C19 in Cancer Patients: Studies to Determine the Prevalence and the Possible Molecular Mechanisms of This Genotype- Phenotype Discordance's thesis committee member is recorded as Studies to Determine the Prevalence and the Possible Molecular Mechanisms of This Genotype- Phenotype Discordance — thesis committee member (P9161): Malcolm D. Tingle[17].
- Acquired Loss of Function of CYP2C19 in Cancer Patients: Studies to Determine the Prevalence and the Possible Molecular Mechanisms of This Genotype- Phenotype Discordance's thesis committee member is recorded as Studies to Determine the Prevalence and the Possible Molecular Mechanisms of This Genotype- Phenotype Discordance — thesis committee member (P9161): Graeme Finlay[18].
Body
Designation and Status
Acquired Loss of Function of CYP2C19 in Cancer Patients: Studies to Determine the Prevalence and the Possible Molecular Mechanisms of This Genotype- Phenotype Discordance's instance of is recorded as Studies to Determine the Prevalence and the Possible Molecular Mechanisms of This Genotype- Phenotype Discordance — instance of (P31): doctoral thesis[3].